
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Hypopituitarism risk factors
Introduction
Overview
Overview
Common risk factors in the development of hypopituitarism may include pituitary tumor or space occupying lesion, pituitary apoplexy, severe blood loss such as Sheehan’s syndrome, pituitary surgery, cranial radiation, genetic defects, hypothalamic disease, immunosuppression, inflammatory processes, pituitary infarction, and non-compliance with hormone replacement therapy. Less common risk factors, include infiltrative disorders, traumatic brain injury causing skull fractures, ischemic stroke and subarachnoid hemorrhage.
Risk Factors
Risk Factors
Common risk factors
Common risk factors of hypopituitarism include the following: [1][2][3][4][3][5][6][7][8]
- Pituitary tumor or space occupying lesion
- Pituitary apoplexy
- Severe loss of blood, such as Sheehan syndrome or postpartum hypopituitarism
- Pituitary surgery, such as hypophysectomy
- Cranial radiation
- Genetic defects
- Hypothalamic disease
- Immunosuppression, such as HIV and high dose glucocorticoid intake
- Inflammatory processes such as hypophysitis
- Pituitary infarction
- Non-compliance with hormone replacement therapy
Less common risk factors
Less common risk factors include:
- Infiltrative disorders such as sarcoidosis and histiocytosis[9]
- Traumatic brain injury causing skull fractures[10][11][12][13][14]
- Ischemic stroke[15]
- Subarachnoid hemorrhage[11][16][17][18]
References
References
- β Khajeh L, Blijdorp K, Neggers SJ, Ribbers GM, Dippel DW, van Kooten F (2014). “Hypopituitarism after subarachnoid haemorrhage, do we know enough?”. BMC Neurol. 14: 205. doi:10.1186/s12883-014-0205-0. PMCΒ 4207357. PMIDΒ 25312299.
- β Vance ML (1994). “Hypopituitarism”. N. Engl. J. Med. 330 (23): 1651β62. doi:10.1056/NEJM199406093302306. PMIDΒ 8043090.
- β 3.0 3.1 Jahangiri A, Wagner JR, Han SW, Tran MT, Miller LM, Chen R, Tom MW, Ostling LR, Kunwar S, Blevins L, Aghi MK (2016). “Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis”. J. Neurosurg. 124 (3): 589β95. doi:10.3171/2015.1.JNS141543. PMIDΒ 26252454.
- β Snyder PJ, Fowble BF, Schatz NJ, Savino PJ, Gennarelli TA (1986). “Hypopituitarism following radiation therapy of pituitary adenomas”. Am. J. Med. 81 (3): 457β62. PMIDΒ 3092668.
- β Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML (1989). “Hypopituitarism following external radiotherapy for pituitary tumours in adults”. Q. J. Med. 70 (262): 145β60. PMIDΒ 2594955.
- β Eastman RC, Gorden P, Roth J (1979). “Conventional supervoltage irradiation is an effective treatment for acromegaly”. J. Clin. Endocrinol. Metab. 48 (6): 931β40. doi:10.1210/jcem-48-6-931. PMIDΒ 447799.
- β Harbeck B, Klose S, Buchfelder M, Brabant G, Lehnert H (2011). “Hypopituitarism in a HIV affected patient”. Exp. Clin. Endocrinol. Diabetes. 119 (10): 633β5. doi:10.1055/s-0031-1284366. PMIDΒ 21922454.
- β Morichika D, Sato-Hisamoto A, Hotta K, Takata K, Iwaki N, Uchida K, Minami D, Kubo T, Tanimoto M, Kiura K (2014). “Fatal Candida septic shock during systemic chemotherapy in lung cancer patient receiving corticosteroid replacement therapy for hypopituitarism: a case report”. Jpn. J. Clin. Oncol. 44 (5): 501β5. doi:10.1093/jjco/hyu019. PMIDΒ 24646812.
- β Kaltsas GA, Powles TB, Evanson J, Plowman PN, Drinkwater JE, Jenkins PJ, Monson JP, Besser GM, Grossman AB (2000). “Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment”. J. Clin. Endocrinol. Metab. 85 (4): 1370β6. doi:10.1210/jcem.85.4.6501. PMIDΒ 10770168.
- β Edwards OM, Clark JD (1986). “Post-traumatic hypopituitarism. Six cases and a review of the literature”. Medicine (Baltimore). 65 (5): 281β90. PMIDΒ 3018425.
- β 11.0 11.1 Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, Stalla GK, Ghigo E (2007). “Hypopituitarism”. Lancet. 369 (9571): 1461β70. doi:10.1016/S0140-6736(07)60673-4. PMIDΒ 17467517.
- β Benvenga S, CampennΓ A, Ruggeri RM, Trimarchi F (2000). “Clinical review 113: Hypopituitarism secondary to head trauma”. J. Clin. Endocrinol. Metab. 85 (4): 1353β61. doi:10.1210/jcem.85.4.6506. PMIDΒ 10770165.
- β Lieberman SA, Oberoi AL, Gilkison CR, Masel BE, Urban RJ (2001). “Prevalence of neuroendocrine dysfunction in patients recovering from traumatic brain injury”. J. Clin. Endocrinol. Metab. 86 (6): 2752β6. doi:10.1210/jcem.86.6.7592. PMIDΒ 11397882.
- β Agha A, Thornton E, O’Kelly P, Tormey W, Phillips J, Thompson CJ (2004). “Posterior pituitary dysfunction after traumatic brain injury”. J. Clin. Endocrinol. Metab. 89 (12): 5987β92. doi:10.1210/jc.2004-1058. PMIDΒ 15579748.
- β Bondanelli M, Ambrosio MR, Carli A, Bergonzoni A, Bertocchi A, Zatelli MC, Ceruti S, Valle D, Basaglia N, degli Uberti EC (2010). “Predictors of pituitary dysfunction in patients surviving ischemic stroke”. J. Clin. Endocrinol. Metab. 95 (10): 4660β8. doi:10.1210/jc.2010-0611. PMIDΒ 20660027.
- β Klose M, Brennum J, Poulsgaard L, Kosteljanetz M, Wagner A, Feldt-Rasmussen U (2010). “Hypopituitarism is uncommon after aneurysmal subarachnoid haemorrhage”. Clin. Endocrinol. (Oxf). 73 (1): 95β101. doi:10.1111/j.1365-2265.2010.03791.x. PMIDΒ 20105184.
- β Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, Stalla GK, Agha A (2007). “Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review”. JAMA. 298 (12): 1429β38. doi:10.1001/jama.298.12.1429. PMIDΒ 17895459.
- β Hannon MJ, Behan LA, O’Brien MM, Tormey W, Javadpour M, Sherlock M, Thompson CJ (2015). “Chronic hypopituitarism is uncommon in survivors of aneurysmal subarachnoid haemorrhage”. Clin. Endocrinol. (Oxf). 82 (1): 115β21. doi:10.1111/cen.12533. PMIDΒ 24965315.
β β
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2] Iqra Qamar M.D.[3]
